Rocket Lab (RKLB) shares traded sharply lower during the week of November 2, 2026, closing near $46 after a 12% single-day drop on elevated volume amid lingering concerns over the Neutron medium-lift rocket’s delayed 2027 debut and margin revisions. Analyst consensus remains a moderate buy with average 12-month price targets near $102, though several firms trimmed targets in late October following the schedule shift. Record Electron launch cadence, a $2.36 billion backlog, and recent multi-year contracts continue to underpin long-term growth expectations, while Q3 2026 results—due November 9 with revenue guided at $250–265 million—represent the immediate catalyst that could influence near-term price action and implied probabilities around weekly trading levels.